Work Fatigue Fuels Stimulant, Sleep Aid Use Risks

A narrative review from the University Medical Center Hamburg-Eppendorf finds that people are turning to stimulants, sleep aids, and painkillers to manage work fatigue, with short-term benefits often leading to long-term health costs.

When Chemical Coping Replaces Rest

Researchers led by S. Milin and I. Schäfer analyzed studies on “performance-enhancing substance use.” They identified a clear pattern: people reach for these compounds during periods of high cognitive demand, stress, emotional strain, and, most frequently, fatigue. This often occurs alongside presenteeism—working while unwell. The review, published in Bundesgesundheitsblatt, frames this behavior not as a personal failing but as a widespread coping mechanism for workplace environments characterized by workload compression and few recovery opportunities.

The substances themselves fall into distinct categories. Stimulants, like prescription medications for ADHD or illegal drugs, aim to prolong alertness. Mood- or sleep-regulating agents, such as melatonin or sedatives, attempt to manage stress or force sleep. Over-the-counter and prescription painkillers address physical complaints that interfere with work. Dietary supplements, a broad and less-regulated category, are also widely used for perceived performance benefits. The distinction is critical; except for most supplements, these substances carry significant medical and legal risks.

Limited Benefits, Substantial Long-Term Risks

The perceived advantage of these substances is narrowly focused. Evidence suggests they primarily support short-term performance demands. For a person facing an urgent deadline while exhausted, a stimulant may provide a few more hours of focused work. However, Milin’s team notes these benefits are “limited and context dependent.” They do not enhance underlying ability or create sustainable energy.

These short-term gains come with a considerable price. The review details risks including the development of tolerance (needing more for the same effect), dependence, and residual side effects like agitation or drowsiness that can impair safety. Perhaps the most significant finding is the trade-off: “Short-term benefits are often offset by long-term health and functional costs.” Using a substance to bypass fatigue today can degrade overall health, sleep architecture, and cognitive reserve tomorrow, creating a vicious cycle that increases reliance on the substance. This pattern mirrors issues discussed in our article on prescription drug use at work.

Napping as a Physiological Countermeasure

If chemical aids are a flawed answer to fatigue, what is a better one? The science of sleep points to a powerful, zero-cost intervention: the brief nap. Research specific to high-stakes professions demonstrates its efficacy. For instance, studies have shown that a 30-minute nap can boost doctor performance by 7.4%, effectively reversing the cognitive decline associated with sleep deprivation and long shifts.

The mechanism is rooted in brain physiology. During a short nap (20-30 minutes), you primarily access stages 1 and 2 of non-rapid eye movement (NREM) sleep. This period is associated with a clearing of adenosine, a neurochemical that accumulates in the brain while you are awake and promotes sleep pressure. By reducing adenosine, a nap reduces the perception of fatigue and restores alertness without the sleep inertia often caused by longer naps that enter deep sleep. It is a targeted reset for the brain’s alertness systems, contrasting sharply with the broad, and often disruptive, pharmacological action of stimulants.

Implementing Rest for Sustainable Performance

The Hamburg review concludes that performance-related substance use can be an indicator of “structural stressors.” Therefore, effective solutions must address these structures. For organizations, this means creating cultures that prioritize sustainable performance through intentional rest. Practical steps include educating employees on sleep health, destigmatizing rest, and where possible, providing access to quiet, dark spaces for short breaks.

For individuals, the goal is to build habits that prevent the intense fatigue that triggers the desire for chemical aids. This starts with protecting nighttime sleep, as chronic sleep deprivation cannot be fully solved by napping. When midday fatigue hits, a planned 20-minute nap is a more effective and safer tool than caffeine or other stimulants. For those struggling with sleep anxiety that affects nighttime rest, evidence-based natural aids like magnesium and L-theanine may support the sleep process without the dependency risks of prescription sleep regulators.

The evidence presents a clear choice: we can manage fatigue with external substances that offer diminishing returns and increasing harm, or we can invest in the innate, restorative power of sleep and planned rest. The sustainable path forward requires recognizing rest not as unproductive time, but as a non-negotiable foundation for cognitive health and performance.

Sources:
https://pubmed.ncbi.nlm.nih.gov/42246992/
https://pubmed.ncbi.nlm.nih.gov/42228614/
https://pubmed.ncbi.nlm.nih.gov/42222553/